Chapter 826: First batch of 400,000 copies, revenue of 5.04 billion US dollars! 165 days of vacation a year?
"Isn't this setting Sen Ge up for a fool?"
"Brother Sen and you are of one mind, are you trying to outsmart Brother Sen?"
"How is this different from insurance fraud?"
"That's not quite right. The annual premium of 2,999 yuan is not cheap, and even if you do get Alzheimer's disease, you won't get cash compensation. You can only enjoy the purchase price of Brain Shield at 10% of the original price."
"Brother Sen, I'm sorry, I didn't mean to cheat you, but my family really has no money left."
"Once my dad gets better, I'll go work in a coastal city. I'll definitely buy more products from Senlian Group to repay Brother Sen."
While purchasing "Alzheimer's disease prevention insurance," netizens shared their real experiences on social media platforms with a deep sense of guilt.
To their surprise, Semir Online seemed to turn a blind eye and didn't care at all about these customers' "suspected insurance fraud" behavior.
Even if someone was diagnosed with Alzheimer's disease ten years ago, Semir Online can still approve their insurance purchase and claim on the same day.
In just two days, this insurance policy sold 260,000 policies, generating revenue of 780 million yuan.
at the same time.
The drug sales licenses issued by the United States have also accelerated the domestic review process.
On August 3, Orange Medical successfully obtained the domestic Drug Registration Certificate and Drug Marketing License.
For the mainland market, Brain Shield is priced at 1200 yuan per pill, with 12 pills constituting one course of treatment, and one pill is taken per week.
Under normal circumstances, it only takes 4 to 6 treatments to restore more than 70% of the patient's original cognitive abilities.
In other words, patients who have purchased "Alzheimer's disease prevention insurance" only need to pay 480 yuan per month.
The total medical cost is about 6,000 yuan, and with the insurance premium, the total is only 9,000 yuan.
This amount is easily affordable for the vast majority of ordinary people.
If the treatment is spread over 12 to 18 months, the stress will be even less.
However, if you don't buy insurance, the total cost will soar to 60,000 yuan.
When the pricing standard was announced, some people were overjoyed and wept with gratitude, thanking Orange Healthcare for not setting the price at a level that ordinary people could not afford after developing the new drug.
Of course, some people were sarcastic, arguing that Chen Yansen, being wealthy, should be able to keep the price of his brain shield down to just a few dollars.
Ideally, it should be priced the same as Vitamin C, costing only a few dollars per bottle, rather than costing 1200 dollars per pill.
However, once the pricing for BrainShield in the North American market was announced, the criticisms and sarcastic remarks vanished instantly.
In overseas markets, a single Brain Shield can cost as much as $3,000, which is 15.5 times the price in China.
This practice may seem unreasonable, but in reality, almost all blockbuster innovative drugs, especially oncology drugs, rare disease drugs, and Alzheimer's drugs, are priced significantly differently in different countries and regions.
This is known as tiered pricing or differentiated pricing, and it is a publicly, legally, and widely adopted business model in the global pharmaceutical industry.
Selling the same drug at a price difference of 5 to 50 times in different countries is not only legal, but also standard practice in the global pharmaceutical industry.
As long as Orange Healthcare does not proactively and publicly admit in high-priced sales areas that "I only sell at one-tenth the price in a certain region," it will not trigger the local "most-favored-nation clause" or a boycott crisis.
Relevant departments in various countries will tacitly accept this "global distribution pricing".
After all, that's what they've always done!
The reasons behind this are quite simple: on the one hand, it's about using technology for good, and on the other hand, it's about maximizing profits.
Take Southeast Asia, South America and Africa for example. People in these regions have limited purchasing power. Does that mean they should just wait to die if they can't afford medicine?
For pharmaceutical companies, even small profits add up to substantial gains.
On the other side.
The National Association of Drug Registrants (NADG) immediately contacted Song Yongping, hoping to obtain a more favorable centralized procurement price and include NeuroGuard in the Medicare Part B procurement plan, which is the North American health insurance plan.
Song Yongping naturally agreed and, under the name of Orange Healthcare, reduced the price of a single treatment course by $6,000, a move that garnered a lot of positive feedback in North America.
In other words, the original cost of a course of treatment was $30,000, but with Medicare and Orange Health assistance, North American patients can actually pay as little as $6,000, making it affordable.
However, from Orange Healthcare's perspective, the price for a single treatment course is still $30,000.
If you do not use the Medicare plan, the cost will be the original price of $36,000.
This price may seem high, but NeuroGuard's pricing is actually very reasonable.
For example, the cost of nusinersen sodium, a treatment for spinal muscular atrophy, is as high as $750,000 in the first year.
The cancer immunotherapy drug pembrolizumab costs $170,000 a year.
Lencatumab, which can inhibit mild Alzheimer's disease, costs $28,000 per year.
NeuroGuard can help patients with severe Alzheimer's disease, and the annual cost is only $36,000, which is a very reasonable price.
Of course, this is true all over the world; without health insurance and supplemental commercial medical plans, very few people can afford it.
Although the production cost of a single pill of this drug is less than 50 cents, it did not prevent Chen Yansen from setting the price at 3,000 US dollars per pill.
In his view, only by earning substantial profits can technical personnel be encouraged to devote their energy to the research and development of new drugs.
An ecosystem without profit motives is like a stagnant pool!
In addition, the pricing standard in Western European countries such as Germany, Italy, and France is US$21,600 per course of treatment, which is equivalent to 60% of the North American standard.
In response, representatives from organizations such as Germany's IQWiG, the UK's NICE, and France's HAS traveled to Luzhou to communicate with Song Yongping.
Firstly, it aims to advance NeuroGuard's IPO plans, and secondly, it seeks to further reduce procurement prices through centralized procurement.
The price in Korea is 65% of that in the United States, 95% in Japan, 55% in Australia, and 25% in Southeast Asia.
No matter how you look at it, BrainShield's pricing in China is the lowest in the world, and the "Alzheimer's disease insurance" is only available to Chinese people.
Semir Online has not opened this insurance product to overseas markets.
In an instant, online public opinion became completely unified. Anyone who dared to say a bad word about Chen Yansen would be relentlessly attacked by netizens until they deleted their social media accounts.
At the same time.
After obtaining the domestic license, Song Yongping also discussed centralized procurement cooperation with the Medical Insurance Association.
After some communication, the purchase price of the medication for a single course of treatment was reduced to 9,600 yuan, or 800 yuan per pill.
It's six or seven times more expensive than the discounted price after purchasing insurance!
However, after medical insurance reimbursement, each pill only requires an individual payment of 160 yuan, with the remaining 640 yuan deducted from the medical insurance card's pooled account.
This method is suitable for patients who have not purchased insurance.
The current problem is that the first planting area of the Super Rice 2000 T2 generation is only 100 mu, which is only 200,000 kilograms of raw materials, enough to produce only 400,000 courses of treatment.
To ensure a full supply, we'll have to wait until the next season of Super Rice 2000 matures.
Therefore, the first batch of production capacity was extremely sought after, and 110,000 treatments of NeuroGuard were sold in less than a day after the online pre-order link for overseas markets was released.
It's worth noting that a course of treatment costs $36,000. Although the price is high, North America is a global hub for the pharmaceutical market, and a small group of wealthy people can still afford it. Moreover, sales in the European market are also quite good.
The 200,000 domestic quotas sold out on the same day, with a transaction amount of 288 million yuan. The buyers were all users who had purchased "Alzheimer's disease prevention insurance" and were eligible for claims.
The 200,000 overseas quotas sold out at 4 a.m. on August 4, with a total transaction value of US$5.04 billion.
Of course, this is only the price that is not included in the medical plans of various countries.
Domestic sales are not even a fraction of those in overseas markets.
Some unscrupulous scalpers have begun to forge medical records, hoping to profit from the price difference by using brain shields.
Because by selling a bottle of brain shield to a private medical institution in the United States, one can earn nearly 200,000 yuan.
Money is a powerful lure, and such temptation makes it hard for people not to take risks.
Faced with this situation, Orange Healthcare had no choice but to join forces with drug regulatory authorities, inspection stations, and customs to rigorously investigate any impending drug resale activities.
Ironically, BrainShield has already sold over 5 billion US dollars worth of products even though it doesn't have half of its stock available.
The pharmaceutical production base in Luzhou is also working overtime to meet demand. Once the first batch of drugs sold out, the pre-order link was immediately taken offline.
As for the next batch of drugs?
Sorry, we'll have to wait three months. We'll only have enough raw materials after the 1,400 mu of super rice in Abyssinia is harvested.
It's not that Chen Yansen doesn't want to make money, but the number of seeds is limited, and some need to be reserved for F1 generation hybrid breeding experiments. It's already quite good that he can produce 400,000 doses of single-course drug.
However, some people in China are speculating on drug prices, and scalpers are also causing trouble overseas.
Many people who managed to snag a NeuroGuard initial release have been reselling it on the dark web for as much as $50,000 per treatment.
Upon learning this, Chen Yansen shook his head helplessly.
It's human nature; it's the same all over the world.
Only when the production capacity of Super Rice 2000 is increased can NeuroGuard truly open up its market.
During this period, Song Yongping met with staff from drug regulatory associations of various countries every day to discuss centralized procurement prices.
But the happiest people are the employees of Orange Bio and Orange Pharmaceutical.
The company has decided to increase employees' salaries by 10% to 30% based on their daily work performance and contributions to scientific research.
In an internal email, Chen Yansen also mentioned that a quarterly bonus of 1.5 times the normal rate would be issued in the third quarter, and that the two companies would be officially included in the "four days on, three days off" work schedule.
Chen Yansen's move sent a clear signal internally.
As long as you can create value for the company, we are never stingy with salary increases and bonuses, and you can also enjoy a more relaxed work system.
As the workload increases, it naturally becomes necessary to recruit more R&D engineers and frontline workers.
For others, rising labor costs are a bad thing, but for Chen Yansen, it's a great thing.
The workload that originally required five people now requires 6.5 people to complete, taking into account a 10% employee leave rate.
This creates 1.5 additional job positions.
This is a really good thing!
In 2015, Senlian Group took the lead in implementing the "four days on, three days off" work system on a large scale.
In the eyes of European and American netizens, this is simply a "miracle company".
As a result, a large number of "Chinese enthusiasts" and "Chen Yansen followers" have emerged on Mimo, Facebook, and YouTube. The praise in the comments section is so overwhelming that even Chen Yansen himself would blush, practically praising him to the skies.
"I plan to learn Chinese and work in China! Do you know what a four-day work week with three days off means? You only have to work 208 days a year. I heard that the Senlian Group also has a bridge vacation system, which gives you about 165 days off a year!"
"I suggest finding a Chinese boyfriend on Mimo; you can practice your spoken English for free."
"Chinese is so hard to learn, I feel like I can't even speak properly. Please give me a Chinese guy."
In the discussion forums of overseas social media, many people are considering finding Chinese partners in order to learn Chinese and try to get a job at the Senlian Group.
Moreover, Senlian Group offers generous compensation and benefits, and has branches in many countries and regions around the world.
When these foreigners learned that employees of Senlian Group could enjoy an additional 40% discount on medication on top of the special price offered by the "Alzheimer's Disease Prevention Insurance," their determination to work for Chen Yansen became even stronger.
People in Europe and America, especially those with family members suffering from Alzheimer's disease, are revising their resumes and searching for opportunities to join the Senlian Group in order to save money.
By August 7, the price of NeuroGuard on the overseas black market had soared to $80,000 per box.
The reason it can sell for this price is entirely due to the "living signboard" of Bill Gates' father and Benson.
A person with severe Alzheimer's disease can now play golf and walk.
Another patient with mild symptoms is now able to chair the board and drive the team's quarterly development.
This is enough to show that NeuroGuard is dozens of times more effective than targeted drugs developed by pharmaceutical giants such as Pfizer, Merck, and Amgen.
Prior to this, there had never been any drugs that could repair lesions in the brain nerves.
Compared to its therapeutic effects, its price is not high.
It can only be said that Chen Yansen manipulated regional pricing, reducing the actual domestic price to 120 yuan per piece.
But wealthy people overseas don't care. Even though they are not sick, it doesn't stop them from spending a lot of money on medicine.
For them, tens of thousands of yuan is just a moderately priced health supplement!
...
...
On Friday evening, Chen Yansen was just about to leave work when his cell phone rang.
He picked it up and saw it was Tang Zhenzhe, so he pressed the answer button.
"Brother Sen, I'm back," Tang Zhenzhe said with a grin.
Last time he wanted to organize a class reunion, but the time was difficult to coordinate. The class of more than forty people discussed it for more than two months before finally setting the date for August 8th.
"I'll book a private room. You can invite Xiaopeng and Bobo over for a get-together tonight."
Chen Yansen thought for a moment and then said.
"Oh, right, Brother Sen, Song Yang is also in Luzhou."
Tang Zhenzhe added a sentence.
In their dormitory 8302, Wang Zhengqiang passed the civil service exam after graduation and became a civil servant in the prefecture, so he gradually lost contact with the others.
Last year, he had a daughter and settled into a peaceful life with his wife, child, and a warm bed.
Song Yang runs a guesthouse on Qingdao Island and also owns three medium-sized hotels. He usually spends his time either flirting with girls on the pier or fishing by the sea. He is probably the one in the dormitory who lives the most carefree life.
Zhu Xiaopeng and Meng Xibo are still working in the customer service department of Pinbei. Because they joined the company early, they are considered project veterans and hold tens of thousands of Pinbei shares. They are living a relatively comfortable life.
Tang Zhenzhe is the only one who spends most of his time in Southeast Asia. Fortunately, he has an outstanding talent for languages and is fluent in both Annamese and English. He is now the sales director of Orange Technology's Annamese market and earns an annual salary of over one million yuan.
(End of this chapter)
Continue read on readnovelmtl.com
